By Iain Gilbert
Date: Wednesday 11 Oct 2023
(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.
Grant of Options | 15-Nov-2023 | 07:00 | RNS |
Appointment of New Chief Financial Officer | 11-Oct-2023 | 07:00 | RNS |
Interim Results | 21-Sep-2023 | 07:00 | RNS |
Result of AGM | 29-Jun-2023 | 18:02 | RNS |
Annual General Meeting Presentation | 29-Jun-2023 | 10:00 | RNS |
AstraZeneca buys the rights to an asthma treatme... | 13-Jun-2014 | Daily Mail |
AstraZeneca in new £138million asthma drug deal | 13-Jun-2014 | Express & Star |
Market report: Monday latest | 24-Sep-2007 | Daily Mail |
The Week Ahead: Wolseley should build on its sol... | 24-Sep-2007 | The Independent |
Questor: Synairgen | 11-May-2007 | Telegraph |
The Week Ahead: Wolseley investors seek calm ami... | 19-Mar-2007 | The Independent |
Retailers the focus of City attention | 18-Sep-2006 | The Scotsman |
No recent information was found.
Currency | UK Pounds |
Share Price | 5.79p |
Change Today | 0.050p |
% Change | 0.87 % |
52 Week High | 9.80 |
52 Week Low | 4.88 |
Volume | 136,690 |
Shares Issued | 201.37m |
Market Cap | £11.66m |
RiskGrade | 510 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:02 | 20,000 @ 5.68p |
15:27 | 25,600 @ 5.68p |
12:04 | 15,000 @ 5.87p |
12:00 | 16,105 @ 5.94p |
11:57 | 1,200 @ 6.08p |
You are here: research